PlainRecalls
FDA Drug Moderate Class II Ongoing

Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Twice-a-Day Dosage, 100 Capsules per bottle, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ, 07430, Product of India, NDC 68462-562-01.

Reported: May 1, 2024 Initiated: April 17, 2024 #D-0472-2024

Product Description

Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Twice-a-Day Dosage, 100 Capsules per bottle, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ, 07430, Product of India, NDC 68462-562-01.

Reason for Recall

Failed Dissolution Specifications

Details

Units Affected
3,264 bottles
Distribution
Nationwide in the USA.
Location
Mahwah, NJ

Frequently Asked Questions

What product was recalled?
Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Twice-a-Day Dosage, 100 Capsules per bottle, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ, 07430, Product of India, NDC 68462-562-01.. Recalled by Glenmark Pharmaceuticals Inc., USA. Units affected: 3,264 bottles.
Why was this product recalled?
Failed Dissolution Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on May 1, 2024. Severity: Moderate. Recall number: D-0472-2024.